August 28, 2023 9:01 AM | 1 min read
Today’s top stories for NVIDIA Corporation (NASDAQ:NVDA) span regulatory challenges in the Chinese market, record-breaking stock performance, and an expanded partnership with VMware in the realm of generative AI.
Regulatory Hurdles in China:
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you’ll also get Benzinga’s ultimate morning update AND a free $30 gift card and more!
NVIDIA’s permission from the U.S. government to develop and export its H100 chip for the Chinese market is nearing its expiration date.
Although a new authorization has been secured, allowing R&D to continue, the direct sale of A100 and H100 chips in China remains prohibited. NVIDIA has cautioned that further U.S. restrictions could result in losing the Chinese market, the largest global market for semiconductors.
The looming expiration of the authorization period could disrupt NVIDIA’s operations, Min News reports.
Record Stock Performance:
NVIDIA’s stock recently hit an all-time high following a third consecutive revenue forecast that surpassed Wall Street expectations.
The company anticipates sales of around $16 billion in the upcoming quarter, outdoing analysts’ estimates of $12.5 billion.
This robust performance is largely attributed to NVIDIA’s pivotal role in the AI computing surge, which has helped it recover swiftly from the global chip shortage and even surpass Intel’s quarterly sales for the first time, Daily Item reports.
Expanded Partnership with VMware:
NVIDIA and VMware have unveiled the VMware Private AI Foundation with NVIDIA, a platform designed to facilitate the development and deployment of generative AI applications for enterprises.
This collaboration aims to address data privacy, security, and control concerns by combining NVIDIA’s accelerated computing and generative AI software with VMware Cloud Foundation.
The platform is slated for launch in early 2024 and is expected to enable businesses to develop custom applications using their own data, Game Is Hard reports.
Disclaimer: This article was developed with the aid of artificial intelligence and Ultima Insights and underwent an editorial review.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
